Recursion Pharmaceuticals Inc (RXRX)

01:02 AM

Is Recursion Pharmaceuticals Inc. stock poised for growthCEO Change & Entry Point Strategy Guides - newser.com

01:02 AM

Nov 14, 2025

How Recursion Pharmaceuticals Inc. stock valuations compare to rivalsJuly 2025 Fed Impact & Precise Buy Zone Tips - newser.com

Nov 14, 2025

Nov 14, 2025

Recursion Pharmaceuticals’ Revenue Miss Drives Stock Downward - StocksToTrade

Nov 14, 2025

Nov 14, 2025

Published on: 2025-11-14 18:05:32 - newser.com

Nov 14, 2025

Nov 14, 2025

RXRX Faces Setback as Revenue Misses Estimates - StocksToTrade

Nov 14, 2025

Nov 14, 2025

Recursion Pharmaceuticals’ Financial Struggles: What’s Next? - timothysykes.com

Nov 14, 2025

Nov 14, 2025

Recursion Pharmaceuticals Reports Q3 Revenue Fall Short of Expectations - timothysykes.com

Nov 14, 2025

Nov 14, 2025

Recursion Pharmaceuticals Stock Plummets Amid Q3 Revenue Miss - timothysykes.com

Nov 14, 2025

Nov 14, 2025

Is it time to cut losses on Recursion Pharmaceuticals Inc.Inflation Watch & Verified Short-Term Trading Plans - newser.com

Nov 14, 2025

Nov 14, 2025

Costco, AMD, Recursion Pharmaceuticals, Cipher Mining And Snowflake: Why These 5 Stocks Are On Investors' Radars Today - AOL.com

Nov 14, 2025

Nov 14, 2025

Using Bollinger Bands to evaluate Recursion Pharmaceuticals Inc.Weekly Trading Summary & Risk Managed Investment Strategies - newser.com

Nov 14, 2025

Nov 13, 2025

Change at the top of Recursion as co-founder leaves CEO role - pharmaphorum

Nov 13, 2025

Nov 13, 2025

Has Recursion Pharmaceuticals Inc. formed a bullish divergenceWeekly Market Report & Safe Entry Trade Signal Reports - newser.com

Nov 13, 2025

Nov 12, 2025

Recursion Pharmaceuticals (RXRX): Assessing Valuation Following CEO Appointment and Disappointing Earnings Results - simplywall.st

Nov 12, 2025

Nov 12, 2025

Will earnings trigger a reversal in Recursion Pharmaceuticals Inc.Trend Reversal & Daily Stock Momentum Reports - newser.com

Nov 12, 2025

Nov 12, 2025

Forget Recursion Pharmaceuticals: This Could Be an Even Better Artificial Intelligence (AI) Stock - MSN

Nov 12, 2025

Nov 11, 2025

Will Recursion Pharmaceuticals Inc. stock maintain growth story2025 Valuation Update & Weekly High Return Opportunities - newser.com

Nov 11, 2025

Nov 11, 2025

A $30m Milestone And Leadership Handoff Signal New Chapter For Recursion - Citeline News & Insights

Nov 11, 2025

Nov 11, 2025

How to interpret RSI for Recursion Pharmaceuticals Inc. stockWeekly Trend Report & AI Based Trade Execution Alerts - newser.com

Nov 11, 2025

Nov 10, 2025

Best Biotech Stocks To ConsiderNovember 6th - MarketBeat

Nov 10, 2025

Nov 09, 2025

Promising Biotech Stocks To ConsiderNovember 8th - MarketBeat

Nov 09, 2025

Nov 09, 2025

StockWatch: Recursion Slides on Data Update as New CEO Named - Genetic Engineering and Biotechnology News

Nov 09, 2025

Nov 09, 2025

Top Biotech Stocks To Follow NowNovember 5th - MarketBeat

Nov 09, 2025

Nov 09, 2025

Recursion Pharmaceuticals Hits Day Low at $4.60 Amid Price Pressure - Markets Mojo

Nov 09, 2025

Nov 08, 2025

Will Recursion’s (RXRX) CEO Transition and Roche Milestone Mark a Turning Point for Its AI Strategy? - simplywall.st

Nov 08, 2025

Nov 08, 2025

Recursion Pharmaceuticals Hits Day Low at $4.86 Amid Price Pressure - Markets Mojo

Nov 08, 2025

Nov 07, 2025

Recursion Pharmaceuticals Faces Steep Revenue Miss Amid Market Pressures - StocksToTrade

Nov 07, 2025

Nov 07, 2025

RXRX Revenue Miss Sparks Market Woes - timothysykes.com

Nov 07, 2025

Nov 07, 2025

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Just Reported Third-Quarter Earnings And Analysts Are Lifting Their Estimates - simplywall.st

Nov 07, 2025

Nov 07, 2025

Will Recursion Pharmaceuticals’ (RXRX) New CEO Accelerate Its AI Ambitions and Strategic Partnerships? - Yahoo Finance

Nov 07, 2025

Nov 07, 2025

Recursion Pharmaceuticals Stock (RXRX) Opinions on Q3 Earnings Miss - Quiver Quantitative

Nov 07, 2025

Nov 07, 2025

RXRX Revenue Misses Q3 Expectations, Sparking Market Concerns - timothysykes.com

Nov 07, 2025

Nov 07, 2025

When is the best time to exit Recursion Pharmaceuticals Inc.Market Sentiment Report & Free Low Drawdown Momentum Trade Ideas - newser.com

Nov 07, 2025

Nov 07, 2025

Recursion refreshes leadership with CEO swap—Chutes & Ladders - Fierce Biotech

Nov 07, 2025

Nov 07, 2025

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Q3 2025 Earnings Call Transcript - Insider Monkey

Nov 07, 2025

Nov 07, 2025

RXRX Faces Revenue Shortfall: Investor Panic? - timothysykes.com

Nov 07, 2025

Nov 06, 2025

Recursion outlines $800M cash runway through 2027 as leadership transition and partnership milestones drive next phase - MSN

Nov 06, 2025

Nov 06, 2025

Recursion Pharmaceuticals’ Earnings Call Highlights Growth and Challenges - TipRanks

Nov 06, 2025

Nov 06, 2025

Will RXRX Recover From Earnings Miss? - StocksToTrade

Nov 06, 2025

Nov 06, 2025

RXRX Earnings Miss: What You Need to Know - timothysykes.com

Nov 06, 2025

Nov 06, 2025

Recursion Pharmaceuticals (RXRX): Annual Losses Widen 35.2% Despite 30.1% Forecast Revenue Growth - Yahoo Finance

Nov 06, 2025